Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

12.540
-0.970-7.18%
Volume:13.79M
Turnover:178.17M
Market Cap:22.16B
PE:28.19
High:13.860
Open:13.800
Low:12.500
Close:13.510
52wk High:20.180
52wk Low:9.650
Shares:1.77B
HK Float Shares:1.49B
Volume Ratio:2.20
T/O Rate:0.92%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.445
ROE:12.77%
ROA:4.28%
PB:2.47
PE(LYR):28.19
PS:6.81

Loading ...

Innocare Pharma Shares Surge Over 5% on Positive Phase III Data for Tafasitamab Combo in Frontline DLBCL

Stock News
·
Jun 18

INNOCARE Issues 8 Million Restricted Shares Under Incentive Plan

Stock News
·
Jun 16

InnoCare issues 8.00 million restricted shares (0.45% stake) in first tranche of 2026 RMB Share Incentive Scheme

Bulletin Express
·
Jun 16

InnoCare Pharma: Shareholders Overwhelmingly Approve All 24 Resolutions at 2026 AGM

Bulletin Express
·
Jun 16

Innovative Drug Stocks See Broad Gains as Sector's Outbound Licensing Activity Remains Robust, Supported by Policy Tailwinds and Commercialization Progress

Stock News
·
Jun 12

Innocare Appoints Yuan Bei as Joint Company Secretary

Stock News
·
Jun 05

A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Jun 03

InnoCare Pharma Gets Acceptance for ITP New Drug Application; Shares Up 3%

MT Newswires Live
·
May 29

Innocare's New Drug Application for Orelabrutinib in ITP Accepted for Review by NMPA

Stock News
·
May 28

InnoCare Pharma Wins Australia Approval for Lymphoma Drug

MT Newswires Live
·
May 28

Innocare Pharma's Orelabrutinib Receives Marketing Authorization from Australian TGA

Stock News
·
May 27

InnoCare Pharma to Vest Over 2.4 Million Shares for 74 Employees

MT Newswires Live
·
May 26

Innocare Shares Surge Over 4% in Afternoon Trading Following Milestone in Novel Anti-Inflammatory Drug Trial

Stock News
·
May 21

InnoCare Pharma Unit Doses First Patient in Autoimmune Disease Drug Trial

MT Newswires Live
·
May 13

InnoCare and Zenas BioPharma Dose First Subject in Phase 1 Study of Oral IL-17AA/AF Inhibitor ICP-054

Bulletin Express
·
May 13

Innocare Announces First Patient Dosed in Phase 1 Trial for Oral IL-17 Inhibitor ICP-054 (ZB021)

Stock News
·
May 13

A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Pullback

Simply Wall St.
·
May 11

Is It Time To Reassess InnoCare Pharma (SEHK:9969) After Its Strong One-Year Share Price Gain?

Simply Wall St.
·
May 08

InnoCare Pharma Maintains Stable Share Capital in April; 14.04 Million Shares Remain under Incentive Schemes

Bulletin Express
·
May 07

INNOCARE Shares Rise Nearly 3% on ASCO 2026 Oral Presentation Selection for Mesutoclax Study

Stock News
·
Apr 28